Hexacare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.80 M
as on 17-11-2024
- Paid Up Capital ₹ 1.80 M
as on 17-11-2024
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 17-11-2024
- Satisfied Charges ₹ 9.00 M
as on 17-11-2024
- Revenue -2.10%
(FY 2023)
- Profit 29.69%
(FY 2023)
- Ebitda -25.95%
(FY 2023)
- Net Worth 11.66%
(FY 2023)
- Total Assets -22.49%
(FY 2023)
About Hexacare Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.80 M and a paid-up capital of Rs 1.80 M.
The company currently has active open charges totaling ₹5.00 Cr. The company has closed loans amounting to ₹9.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sivalingam Aravindh, Arun Kumar, Palani Purushothaman, and Three other members serve as directors at the Company.
- CIN/LLPIN
U51900TN2015PTC101404
- Company No.
101404
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Hexacare Pharmaceuticals Private Limited offer?
Hexacare Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Oral Suspension, Anti Ulcer Drugs, Mesalamine Tablets, Anti Cancer Medicines, Erlotinib Tablets, HIV Drugs, Abamune Tablet, Anti Infective Agent, Tigecycline Injection.
Who are the key members and board of directors at Hexacare Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivalingam Aravindh  | Director | 14-Jul-2015 | Current |
| Arun Kumar | Director | 14-Jul-2015 | Current |
| Palani Purushothaman | Director | 14-Jul-2015 | Current |
| Prasad Kumar | Director | 14-Jul-2015 | Current |
| Balan Dineshkumar | Director | 14-Jul-2015 | Current |
| Arunkumar | Director | 14-Jul-2015 | Current |
Financial Performance of Hexacare Pharmaceuticals.
Hexacare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.1% decrease. The company also saw a substantial improvement in profitability, with a 29.69% increase in profit. The company's net worth Soared by an impressive increase of 11.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hexacare Pharmaceuticals?
In 2023, Hexacare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Oct 2021 | ₹5.00 Cr | Open |
Others Creation Date: 13 Dec 2018 | ₹9.00 M | Satisfied |
How Many Employees Work at Hexacare Pharmaceuticals?
Hexacare Pharmaceuticals has a workforce of 21 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hexacare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hexacare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
